
In this FAQ video module, William Saalfeld, NP, explains the rationale for investigational combination therapy with guselkumab and golimumab in psoriatic arthritis (PsA). He reviews how guselkumab targets interleukin-23...


This is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). Through our peer-to-peer network, we seek to support the integral role APPs play in the rheumatology healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with rheumatic diseases.
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
35%
Guest openness
Selective
Sign up to generate a grounded pitch for RhAPPcast.
Signup to Generate a PitchThis is the official podcast of Rheumatology Advanced Practice Providers (RhAPP), a non-profit 501c3 organization dedicated to developing educational programs, providing professional advancement services, and assembling resources for, and guided by, advanced practice providers (APPs).
Recent episodes include "FAQ: How Does Combination Therapy of Guselkumab and Golimumab Work in PsA?" (29 October 2026, 2 minutes), "Journal Club: Guselkumab + Golimumab in Active PsA: Week 24 Phase 2a Results" (22 October 2026, 4 minutes), and "Medication Review: Belimumab Dosing Strategies and Administration in SLE and Lupus Nephritis" (20 October 2026, 5 minutes).
RhAPPcast publishes roughly a few times a week, with episodes averaging 9 minutes.
Booking probability for RhAPPcast is 35%, and the host is rated Selective on guests. RhAPPcast requires a Pod Score of 80 or higher. RhAPPcast's contact route on record: public web form.
The strongest fits for RhAPPcast are Health & Wellness Services. RhAPPcast has an education audience.
RhAPPcast is an education podcast.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

In this FAQ video module, William Saalfeld, NP, explains the rationale for investigational combination therapy with guselkumab and golimumab in psoriatic arthritis (PsA). He reviews how guselkumab targets interleukin-23...

In this Journal Club, Claudia Rivera-Salas, DNP, discusses the phase 2a AFFINITY trial evaluating combination therapy for active psoriatic arthritis (PsA). She reviews a randomized, double-blind study comparing...

RhAPPcast
In this medication review, Jessica Tapia, NP, a family nurse practitioner in rheumatology at HonorHealth in Phoenix, Arizona, reviews belimumab (Benlysta) dosing for systemic lupus erythematosus (SLE) and lupus...

In this FAQ video module, Amanda Mixon, PA-C, explains the difference between the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and the Ankylosing Spondylitis Disease Activity Score (ASDAS), two validated...

RhAPPcast
In this medication review, Amanda Mixon, PA-C, reviews the APEX and SOLSTICE clinical trials and their implications for guselkumab (Tremfya) in active psoriatic arthritis (PsA). This overview highlights the role of...

Amanda Mixon, PA-C and fellow rheumatology providers Heather Finlayson, PA-C, and Amanda Sell, PA-C, discuss managing glucocorticoid toxicity in polymyalgia rheumatica (PMR), focusing on balancing disease control with...

In this FAQ video module, Jennifer Mylod, a rheumatology nurse practitioner in Phoenix, Arizona, compares the mechanisms of action of guselkumab and icotrokinra within the interleukin-23 (IL-23)/T-helper 17 (Th17)...

RhAPPcast
In this FAQ video, Heather Finlayson, PA-C, discusses how treatment duration should be approached after achieving remission or low disease activity in systemic lupus erythematosus (SLE). As treatment options continue to...

In this episode of RhAPPcast, host Amanda Mixon, PA-C, is joined by Jeannette Hart, PA-C, to discuss lupus disease activity assessment and the distinction between active disease and irreversible organ damage. The...

In this educational Medication Review, Jennifer Mylod, DNP, provides an overview of the biologic and targeted therapies currently available for the treatment of systemic lupus erythematosus (SLE) and lupus nephritis...

In this FAQ video, Amanda Mixon, PA-C, discusses why early intervention is critical in the management of systemic lupus erythematosus (SLE). Early diagnosis and treatment are essential for controlling inflammation...

RhAPPcast
In this RhAPP Journal Club, Danielle Gatti-Palumbo, a clinical pharmacist in rheumatology, reviews the efficacy and safety of deucravacitinib, an oral selective tyrosine kinase 2 (TYK2) inhibitor, in patients with...

RhAPPcast
In this FAQ video module, Tiffany Terrell, NP, reviews the role of early intervention and steroid reduction in minimizing long-term organ damage in systemic lupus erythematosus (SLE) and lupus nephritis. This overview...

RhAPPcast
In this RhAPP FAQ video module, Jennifer Mylod, nurse practitioner at Arizona Arthritis and Rheumatology Associates in Phoenix, Arizona, discusses how autoantibodies help guide diagnosis, prognosis, disease monitoring...

In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, president of RhAPP, is joined by RhAPP board member Kyle George to explore The True Cost of Gout: Work...

In this FAQ video module, Jennifer Mylod, nurse practitioner with Arizona Arthritis Rheumatology Associates in Phoenix, Arizona, discusses key diagnostic considerations and limitations of antibody testing in idiopathic...

RhAPPcast
In this RhAPP journal club video module, Danielle Gatti Palumbo, PharmD, reviews the Phase 3 POETYK PsA-2 clinical trial evaluating deucravacitinib in adults with active psoriatic arthritis. Deucravacitinib is an oral...

In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon leads a multidisciplinary, case-based discussion titled “Cracking the Code: A Rheum-Derm-Neuro...

In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon is joined by RhAPP board member Wendy Simmons to explore uncontrolled gout as a systemic inflammatory...

In this RhAPP journal club video module, Bharati Bhardwaja, PharmD, BCPS, LSSBB, reviews the Phase 3 TOGETHER-PsA clinical trial and its implications for adults with active psoriatic arthritis who are overweight or have...
Recent guests on RhAPPcast. Study who booked and why before you pitch.
Director of Diversity, Inclusion & Belonging, and Talent Acquisition, Riverside Mental Health and Recovery Center
retired lieutenant-colonel in the British Army, Craft Body Scan / Together We Scan
FNP-C, MSN
Director of Product, Society of Dermatology Physician Assistants
PitchCentric classifies RhAPPcast under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ